Phase 3 Polymyalgia Rheumatica Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Polymyalgia Rheumatica
Novartis Pharmaceuticals288 enrolled115 locationsNCT06331312
Recruiting
Phase 3
Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica
Polymyalgia Rheumatica
Zhejiang University98 enrolled1 locationNCT06172361
Recruiting
Phase 2Phase 3
Treatment of glucocorticoid-induced protein wasting
Long-term glucocorticoid users with polymyalgia rheumatica
St Vincent's Hospital24 enrolled1 locationACTRN12605000642684